Top compounds associated with response to USP17L30


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.077 0.04
mRNA PHA-793887 CTRPv2 pan-cancer AAC 0.062 0.05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.05
mRNA BRD-K27224038 CTRPv2 pan-cancer AAC -0.15 0.05
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.064 0.05
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.07 0.05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
mRNA Merck60 CTRPv2 pan-cancer AAC -0.056 0.06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.06
Download CSV